Ka-Yun Ng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ka-Yun Ng has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Yang Liu
Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Campus Box C‐238, 4200 East Ninth Avenue, Denver, Colorado 80262
2 shared publications- Cheong-Weon Cho
College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea
1 shared publication Limin Zhao
1 shared publicationMrinal Mahapatro
1 shared publicationRobert L. Tanguay
Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Campus Box C-238, 4200 East Ninth Avenue, Denver, Colorado 80262
1 shared publicationThomas K. Henthorn
Department of Anesthesiology, School of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262
1 shared publication
Latest Publications
- 1 November 2004
- Published by Elsevier in Drug Discovery Today
- Vol. 9 (21) , 913
Enhancing transdermal drug transport with low-frequency ultrasound
- 1 November 2004
- Published by Elsevier in Drug Discovery Today
- Vol. 9 (21) , 913
Enhancing transdermal drug transport with low-frequency ultrasound
- 1 April 2004
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 93 (4) , 896-907
Effect of Heat Preconditioning on the Uptake and Permeability of R123 in Brain Microvessel Endothelial Cells during Mild Heat Treatment
- 1 April 2004
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 93 (4) , 896-907
Effect of Heat Preconditioning on the Uptake and Permeability of R123 in Brain Microvessel Endothelial Cells during Mild Heat Treatment
- 8 February 2002
- Published by Wiley in Medicinal Research Reviews
- Vol. 22 (2) , 204-223
Therapeutic ultrasound: Its application in drug delivery
Ultrasound is best known for its imaging capability in diagnostic medicine. However, there have been considerable efforts recently to develop therapeutic uses for it. The purpose of this review is to summarize some of the recent advances made in the area of therapeutic ultrasound as they relate to drug delivery. In particular, this review will focus on the applications of ultrasound to enhance the delivery and effect of three distinctive therapeutic drug classes: chemotherapeutic, thrombolytic, and gene‐based drugs. In addition, ultrasound contrast agents have been recently developed for diagnostic ultrasound. New experimental evidence suggests that these contrast agents can be used as exogenous cavitation nuclei for enhancement of drug and gene delivery. Thus, brief review of this new class of agents and their roles in drug delivery will also be provided. By comparison to diagnostic ultrasound, progress in therapeutic use of ultrasound has been somewhat limited. The recent successes in ultrasound‐related drug delivery research positions ultrasound as therapeutic tool for drug delivery in the future. © 2002 John Wiley & Sons, Inc. Med Res Rev, 22, No. 2, 204–223, 2002; DOI 10.1002/med.10004
- 8 February 2002
- Published by Wiley in Medicinal Research Reviews
- Vol. 22 (2) , 204-223
Therapeutic ultrasound: Its application in drug delivery
Ultrasound is best known for its imaging capability in diagnostic medicine. However, there have been considerable efforts recently to develop therapeutic uses for it. The purpose of this review is to summarize some of the recent advances made in the area of therapeutic ultrasound as they relate to drug delivery. In particular, this review will focus on the applications of ultrasound to enhance the delivery and effect of three distinctive therapeutic drug classes: chemotherapeutic, thrombolytic, and gene‐based drugs. In addition, ultrasound contrast agents have been recently developed for diagnostic ultrasound. New experimental evidence suggests that these contrast agents can be used as exogenous cavitation nuclei for enhancement of drug and gene delivery. Thus, brief review of this new class of agents and their roles in drug delivery will also be provided. By comparison to diagnostic ultrasound, progress in therapeutic use of ultrasound has been somewhat limited. The recent successes in ultrasound‐related drug delivery research positions ultrasound as therapeutic tool for drug delivery in the future. © 2002 John Wiley & Sons, Inc. Med Res Rev, 22, No. 2, 204–223, 2002; DOI 10.1002/med.10004
- 1 January 2000
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 193 (2) , 157-166
The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome
- 1 January 2000
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 193 (2) , 157-166
The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome